Cancer research
Phase 1 Clinical Trial to Study Integrating CAR T-Cell Therapy with Bone Marrow Transplant for High-Risk Blood Cancers
The National Cancer Institute (NCI) has listed a Phase 1 clinical trial to study the integration of CAR T-cell therapy with bone marrow transplant, also known as allogeneic hematopoietic cell transplantation, for patients with high-risk blood cancers. The trial, led by principal investigator Christopher G. Kanakry, M.D., aims to